tiprankstipranks
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR

X4 Pharmaceuticals (XFOR) Financial Statements

720 Followers

X4 Pharmaceuticals Financial Overview

X4 Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.795; its P/E ratio is -1.17; X4 Pharmaceuticals is scheduled to report earnings on March 21, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 49.00K$ 48.00K$ 49.00K$ 98.00K$ 0.00
Gross Profit$ 49.00K$ 48.00K$ 49.00K$ 98.00K-
EBIT$ -645.00K$ -54.55M$ -29.18M$ -28.14M$ -20.58M
EBITDA--$ 0.00$ -28.02M$ -20.46M
Net Income Common Stockholders$ -2.31M$ -55.71M$ -24.02M$ -29.10M$ -21.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 141.68M$ 141.31M$ 93.41M$ 121.72M$ 79.86M
Total Assets$ 173.29M$ 173.40M$ 123.42M$ 154.48M$ 113.41M
Total Debt$ 3.96M$ 5.04M$ 5.11M$ 6.12M$ 38.32M
Net Debt$ -137.72M$ -136.27M$ -88.30M$ -115.60M$ -41.54M
Total Liabilities$ 105.70M$ 105.86M$ 72.73M$ 155.59M$ 51.56M
Stockholders Equity$ 67.59M$ 67.50M$ 51.63M$ 74.05M$ 61.85M
Cash Flow-
Free Cash Flow---$ -19.13M$ -19.32M
Operating Cash Flow$ -20.83M--$ -19.09M$ -19.31M
Investing Cash Flow$ -5.16M--$ -34.00K$ -9.00K
Financing Cash Flow$ 21.20M--$ 60.64M$ 51.98M
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

X4 Pharmaceuticals Debt to Assets

X4 Pharmaceuticals Cash Flow

X4 Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis